论文部分内容阅读
作者回顾地尔硫(艹卓)治疗轻～中度高血压(114mmHg≥舒张压>90mmHg)的3项多中心临床试验.第1项试验中,52例服地尔硫(艹卓)(120～360mg/d)12周后卧位血压下降幅度显著大于56例服安慰剂者(-10.9/-10.8对
The authors reviewed three multicentre clinical trials of diltiazem in the treatment of mild to moderate hypertension (114 mmHg ≥ diastolic blood pressure> 90 mmHg). In the first study, 52 patients treated with diltiazem (120- 360mg / d) 12 weeks after the declining blood pressure declination was significantly greater than 56 patients taking placebo (-10.9 / -10.8 pairs